About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Arizona | 16,770 Studies Near You | Clareo Health

Clinical Trials LocationsArizona

Clinical Trials in Arizona

Discover 16,770 clinical trials near Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 12681-12700 of 16,770 trials

TERMINATEDPhase 1/231 miles

Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers

NCT01848756

Hsp90 is a chemical in the body that is involved in the promotion of cancer. SNX-5422 is an experimental drug that blocks Hsp90

Esanex Inc.15 participantsStarted Apr 2013

Scottsdale, Arizona, United States • Washington D.C., District of Columbia, United States • Hackensack, New Jersey, United States +1 more locations

COMPLETED31 miles

ProMRI Study of the Entovis Pacemaker System

NCT01761162

The objective of the ProMRI Study is to demonstrate the clinical safety of the ProMRI Pacemaker System when used under specific MRI conditions.

Safety of the ProMRI Pacemaker System Under Specific MRI Conditions

Biotronik, Inc.229 participantsStarted Feb 2013

Scottsdale, Arizona, United States • Concord, California, United States • Newport Beach, California, United States +22 more locations

Find Trials by Condition in Arizona

Breast Cancerin Arizona Lung Cancerin Arizona Prostate Cancerin Arizona Colorectal Cancerin Arizona Melanomain Arizona Leukemiain Arizona Lymphomain Arizona Pancreatic Cancerin Arizona Ovarian Cancerin Arizona Brain Cancerin Arizona Diabetes

Data from ClinicalTrials.govTerms

COMPLETEDPhase 242 miles

A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

NCT01548287

This is a study where AZD5213 or placebo is given to patients with Mild Alzheimer's Disease or Mild Cognitive Impairment in a blinded and random assignment. The main study objective is to estimate the relationship of sleep duration versus dose after 4 weeks of treatment.

Mild Cognitive ImpairmentMild Alzheimer's Disease

AstraZeneca164 participantsStarted Apr 2012

Phoenix, Arizona, United States • Indio, California, United States • Lomita, California, United States +10 more locations

COMPLETEDNA42 miles

Chlorhexidine Gluconate Oral Care for Adults Experiencing Trauma

NCT01382446

Examine the use of 0.12% Chlorhexidine Gluconate as an adjunct to current oral care protocol for trauma patients on ventilator support to decrease the incidence of Ventilator Associated Pneumonia and oral bacterial load.

Ventilator Associated Pneumonia

St. Joseph's Hospital and Medical Center, Phoenix66 participantsStarted Jul 2010

Phoenix, Arizona, United States

COMPLETEDPhase 242 miles

Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

NCT00528398

RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving idarubicin together with high-dose cytarabine works in treating patients with acute myeloid leukemia.

City of Hope Medical Center111 participantsStarted Sep 1994

Phoenix, Arizona, United States • Duarte, California, United States

COMPLETED108 miles

Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging

NCT00445718

This natural history study is collecting health information about infants with adrenal masses found on prenatal and/or neonatal imaging. Gathering information over time from imaging and laboratory tests of infants with adrenal masses may help doctors learn more about the disease and plan the best treatment.

Adrenocortical CarcinomaLocalized Resectable NeuroblastomaPrecancerous Condition

Children's Oncology Group97 participantsStarted Jul 2001

Tucson, Arizona, United States • Downey, California, United States • Los Angeles, California, United States +42 more locations

COMPLETEDPhase 3257 miles

A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis

NCT01550744

The purpose of the study is to assess the effect of extending maintenance dosing intervals beyond 12 weeks on the clinical efficacy and safety of ustekinumab in subjects with moderate-to-severe plaque psoriasis.

Janssen Biotech, Inc.478 participantsStarted Mar 2012

Birmingham, Alabama, United States • Bakersfield, California, United States • Irvine, California, United States +37 more locations

COMPLETEDPhase 2257 miles

A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer

NCT01427933

This is a study to compare the antitumor activity of ramucirumab (IMC-1121B) and eribulin together versus eribulin alone, in participants with locally recurrent or metastatic breast cancer.

Eli Lilly and Company141 participantsStarted Nov 2011

Birmingham, Alabama, United States • Gilroy, California, United States • Palm Springs, California, United States +49 more locations

COMPLETEDPhase 3269 miles

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries

NCT01754480

This study is designed to assess the safety and efficacy of Fibrin Sealant Grifols in patients undergoing open surgical procedures where bleeding may be present on parenchymous tissue (e.g., solid abdominal organs such as the liver). The purpose of this study is to demonstrate that Fibrin Sealant Grifols is not inferior to commercially-available oxidized cellulose pads (Surgicel®) in providing benefit in the time to hemostasis (i.e, the stoppage of bleeding). This study has a Preliminary Part (I) for study teams to become familiar with the application of Fibrin Sealant Grifols and to assess safety and a Primary Part (II) to assess the safety and efficacy of Fibrin Sealant Grifols. In both parts of the study, patients will be randomized in a 1:1 ratio to either Fibrin Sealant Grifols or Surgicel.

Parenchymous Tissue Surgical Bleeding

Instituto Grifols, S.A.325 participantsStarted Mar 2013

Loma Linda, California, United States • Los Angeles, California, United States • New Haven, Connecticut, United States +30 more locations

COMPLETEDNA339 miles

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

NCT00726934

The purpose of this study is to determine if FDA approved food safety guidelines are equivalent to a low bacterial diet (the neutropenic diet) with respect to the acquisition of infections during neutropenia in a sample of pediatric cancer patients.

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaNon-Hodgkins Lymphoma+2 more

Indiana University149 participantsStarted Sep 2007

San Diego, California, United States • Indianapolis, Indiana, United States • Brooklyn, New York, United States +3 more locations

COMPLETEDPhase 2339 miles

Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

NCT00539929

This is a double-blind, multicenter study to assess the efficacy and safety of E6201 topical administration to pre-identified marker lesions in adult subjects with chronic plaque type psoriasis. Treatment duration is 8 weeks, followed by a 4-week period without treatment. Pharmacokinetic samples will be obtained pre-and post treatment.

Chronic Plaque Psoriasis

Eisai Inc.100 participantsStarted Sep 2007

Hot Springs, Arkansas, United States • San Diego, California, United States • Boise, Idaho, United States +9 more locations

COMPLETEDPhase 3339 miles

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)

NCT01074944

The primary objective of this study was to evaluate the efficacy and safety of once daily (QD) versus twice daily (BID) dosing of eliglustat tartrate (Genz-112638) in participants with Gaucher disease type 1 who had demonstrated clinical stability on BID dosing of eliglustat tartrate (Genz-112638). The secondary objective was to evaluate the pharmacokinetics (PK) of Genz-99067 when eliglustat tartrate (Genz-112638) was administered QD and BID in participants with Gaucher disease type 1 who had demonstrated clinical stability on BID dosing of eliglustat tartrate (Genz-112638).

Gaucher Disease

Genzyme, a Sanofi Company170 participantsStarted Jun 2010

San Diego, California, United States • New Haven, Connecticut, United States • Decatur, Georgia, United States +43 more locations

WITHDRAWNNA367 miles

Managing Wounds With Allevyn Life in a Home Health Care Environment

NCT02776800

When elderly patients need help caring for wounds, physicians may refer patients to home health care providers. The home health provider sees the patient in the patient's home and assists the patient with wound care. Working with the patient's physician, the home health provider will use the appropriate wound covering ("dressing" or "bandage") to cover the wound. The goal of the home health provider is to ensure that the wound stays clean and progresses toward closure. The home health provider will conduct in-home patient visits at appropriate intervals to assess the status of the wound. Extensive resources are required to see patients in their own homes. If a dressing could effectively manage wounds and allow longer time between in-home visits (without affecting patient safety or progress of the wound toward closure), then resources could be saved. Thus, newer dressings are designed for longer wear times, using advanced foam pads and adhesives that help keep the dressing in place. The hypothesis of this study is that the use of Allevyn Life will decrease the number of in-home visits by home health providers without sacrificing patient safety.

Wounds and Injuries

Smith & Nephew, Inc.Started Aug 2016

Tustin, California, United States • Wichita, Kansas, United States • McAllen, Texas, United States

COMPLETEDPhase 2376 miles

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

NCT01667536

This was a multicenter, multi-reader, open-label, Phase 2 study assessing the safety and performance characteristics of MIP 1404 imaging in the detection of prostate gland and pelvic lymph node cancer. Comparative performance characteristics between MIP 1404 imaging and MRI were also assessed, as judged by histopathology results.

Prostate Cancer

Molecular Insight Pharmaceuticals, Inc.105 participantsStarted Aug 2012

Duarte, California, United States • Rochester, Minnesota, United States • New York, New York, United States +32 more locations

COMPLETEDPhase 3378 miles

Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

NCT01079234

This trial is conducted in Europe and in the United States of America (USA). The aim of this trial is to investigate the efficacy and safety of NN1250 (insulin degludec) in subjects with type 1 diabetes.

DiabetesDiabetes Mellitus, Type 1

Novo Nordisk A/S493 participantsStarted Mar 2010

Encino, California, United States • Fresno, California, United States • Huntington Beach, California, United States +79 more locations

COMPLETEDPhase 2388 miles

EPO906 Therapy in Patients With Prostate Cancer

NCT00035113

This study will examine whether the new investigational drug EPO906, given by intravenous infusion (IV directly into the vein), is effective in shrinking tumors and preventing the growth of cells that cause prostate cancer.

Prostatic Neoplasms

Novartis Pharmaceuticals48 participantsStarted Jan 2002

Long Beach, California, United States • San Francisco, California, United States • Baltimore, Maryland, United States +2 more locations

TERMINATEDPhase 1391 miles

First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects

NCT01261767

This trial is conducted in the United States of America (USA). The aim of this clinical trial is evaluate the safety and tolerability of anti-IL-20 in patients with psoriasis and to determine the preliminary efficacy in an expansion phase of this trial. This trial consists of 3 parts: A single dose (SD) dose-escalation phase for 16 weeks, a multiple dose (MD) dose-escalation phase for 22 weeks, and a MD expansion phase for 22 weeks. Initiation of the MD expansion phase will depend on results from the SD and MD dose-escalation phases and only if an acceptable safety profile is present. Subjects participating in the expansion phase are not allowed to have participated in the previous phases (SD and MD dose-escalation phases) of the trial.

InflammationPsoriasis

Novo Nordisk A/S55 participantsStarted Apr 2008

Birmingham, Alabama, United States • Los Angeles, California, United States • Skokie, Illinois, United States +13 more locations

COMPLETEDPhase 1/2486 miles

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

NCT01471782

The purpose of this study is to determine the dose of the bispecific T cell engager blinatumomab (MT103) in pediatric and adolescent patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and to assess whether this dose of blinatumomab is effective.

Acute Lymphoblastic Leukemia

Amgen Research (Munich) GmbH93 participantsStarted Jan 2012

Aurora, Colorado, United States • Atlanta, Georgia, United States • St Louis, Missouri, United States +27 more locations

COMPLETEDPhase 3817 miles

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant

NCT02032875

This trial was open to participants who had received a liver transplant or had cirrhosis due to chronic HCV. All subjects were treated with daclatasvir+sofosbuvir+ribavirin and were followed for 24 weeks post treatment. Under certain conditions, the treatment duration could have been extended for cirrhotic participants. The study tested the efficacy and safety of this combination for treatment of HCV in cirrhotic and post transplant patients.

Bristol-Myers Squibb116 participantsStarted Mar 2014

Miami, Florida, United States • Ann Arbor, Michigan, United States • Houston, Texas, United States +2 more locations

COMPLETEDPhase 2851 miles

Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve Surgery

NCT00903370

The purpose of the research is to determine whether treating atrial fibrillation with surgical ablation during scheduled mitral valve surgery is better than mitral valve surgery by itself without the surgical ablation. Surgical ablation of atrial fibrillation is a technique used by surgeons to deaden atrial heart tissue and block electrical signals that may be causing your heart to beat irregularly. There are no new procedures being tested in this study; both mitral valve surgery and surgical ablation are used regularly in patients who have mitral valve problems and atrial fibrillation, although no surgical ablation devices have been approved by the Food and Drug Administration for the treatment of atrial fibrillation. What is not known with certainty, is whether patients with atrial fibrillation who are having planned mitral valve surgery would do better if they also had surgical ablation rather than medication alone to treat their atrial fibrillation.

Atrial FibrillationMitral Valve InsufficiencyMitral Valve Stenosis

Annetine Gelijns260 participantsStarted Jan 2010

New Haven, Connecticut, United States • Newark, Delaware, United States • Atlanta, Georgia, United States +18 more locations

PreviousPage 635 of 839Next

in Arizona

Heart Diseasein Arizona